Biotech · Private company
MediWound Ltd
Track this companyFree. Adds MediWound Ltd to your Dealase workspace and tells you when its record changes.
Clinical trials83 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- EscharEx (EX-03)Phase 3 · Venous Leg Ulcer (VLU)ClinicalTrials.gov · fetched Nov 12, 2026
- Gel VehiclePhase 3 · Thermal BurnsClinicalTrials.gov · fetched Nov 12, 2026
- NexoBridPhase 3 · Thermal BurnsClinicalTrials.gov · fetched Nov 12, 2026
- EscharEx (5% EX-02 formulation)Phase 2 · Venous Leg UlcerClinicalTrials.gov · fetched Nov 12, 2026
- EscharEx (EX-02 formulation)Phase 2 · Venous Leg UlcerClinicalTrials.gov · fetched Nov 12, 2026
- EscharEx (EX-03)Phase 2 · Venus Leg UlcersClinicalTrials.gov · fetched Nov 12, 2026
- EscharEx 5% (EX-02 formulation)Phase 2 · Superficial Basal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Gel VehiclePhase 2 · Venous Leg UlcerClinicalTrials.gov · fetched Nov 12, 2026
- NexoBridThermal BurnClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- Controlled Study, Performed to Evaluate the Safety and Efficacy of EscharEx and Its Placebo (Gel Vehicle) Compared to Non-surgical Standard of Care in Participants With Venous Leg Ulcers (VLU)PHASE2 · NOT_YET_RECRUITING · started Jan 10, 2027ClinicalTrials.gov NCT06690177 · fetched Nov 12, 2026
- A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)PHASE3 · RECRUITING · started Jun 1, 2025ClinicalTrials.gov NCT06568627 · fetched Nov 12, 2026
- A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell CarcinomaPHASE1_PHASE2 · RECRUITING · started Jun 30, 2021ClinicalTrials.gov NCT05157763 · fetched Nov 12, 2026
- A Study to Evaluate the Clinical Performance, Safety and Pharmacology Effect of EscharEx in Patients With Lower Leg UlcersPHASE2 · COMPLETED · started Apr 21, 2021ClinicalTrials.gov NCT04817228 · fetched Nov 12, 2026
- A Study to Evaluate the Safety and the Efficacy of EscharEx (EX-02 Formulation) in Debridement of Venous Leg UlcersPHASE2 · COMPLETED · started Dec 2, 2019ClinicalTrials.gov NCT03588130 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of NexoBrid in Subjects With Thermal BurnsPHASE3 · COMPLETED · started May 27, 2015ClinicalTrials.gov NCT02148705 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of NexoBrid in Children With Thermal Burns Compared the Standard of CarePHASE3 · COMPLETED · started May 1, 2015ClinicalTrials.gov NCT02278718 · fetched Nov 12, 2026
- Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn InjuriesAPPROVED_FOR_MARKETINGClinicalTrials.gov NCT04040660 · fetched Nov 12, 2026